PlainRecalls
FDA Drug Moderate Class II Ongoing

Levoxyl (levothyroxine sodium tablets, USP), 50 mcg, 100-count bottle, Rx only, Distributed by: Pfizer Inc., New York, NY 10017, Made in Austria, NDC 60793-851-01.

Reported: August 20, 2025 Initiated: July 29, 2025 #D-0575-2025

Product Description

Levoxyl (levothyroxine sodium tablets, USP), 50 mcg, 100-count bottle, Rx only, Distributed by: Pfizer Inc., New York, NY 10017, Made in Austria, NDC 60793-851-01.

Reason for Recall

Subpotent drug

Details

Recalling Firm
Pfizer
Units Affected
29, 004 bottles
Distribution
Within U.S
Location
Manhattan, NY

Frequently Asked Questions

What product was recalled?
Levoxyl (levothyroxine sodium tablets, USP), 50 mcg, 100-count bottle, Rx only, Distributed by: Pfizer Inc., New York, NY 10017, Made in Austria, NDC 60793-851-01.. Recalled by Pfizer. Units affected: 29, 004 bottles.
Why was this product recalled?
Subpotent drug
Which agency issued this recall?
This recall was issued by the FDA Drug on August 20, 2025. Severity: Moderate. Recall number: D-0575-2025.